-
Je něco špatně v tomto záznamu ?
Cdc7 kinase stimulates Aurora B kinase in M-phase
S. Ito, H. Goto, K. Kuniyasu, M. Shindo, M. Yamada, K. Tanaka, GT. Toh, M. Sawa, M. Inagaki, J. Bartek, H. Masai,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
- MeSH
- aparát dělícího vřeténka metabolismus MeSH
- aurora kinasa B metabolismus MeSH
- buněčné dělení MeSH
- buněčný cyklus MeSH
- centromera metabolismus MeSH
- chromozomální proteiny, nehistonové metabolismus MeSH
- fosforylace MeSH
- HCT116 buňky MeSH
- HEK293 buňky MeSH
- HeLa buňky MeSH
- hmyz MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- mitóza MeSH
- mutace MeSH
- nádorové buněčné linie MeSH
- protein-serin-threoninkinasy metabolismus MeSH
- proteiny buněčného cyklu metabolismus MeSH
- survivin metabolismus MeSH
- threonin chemie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The conserved serine-threonine kinase, Cdc7, plays a crucial role in initiation of DNA replication by facilitating the assembly of an initiation complex. Cdc7 is expressed at a high level and exhibits significant kinase activity not only during S-phase but also during G2/M-phases. A conserved mitotic kinase, Aurora B, is activated during M-phase by association with INCENP, forming the chromosome passenger complex with Borealin and Survivin. We show that Cdc7 phosphorylates and stimulates Aurora B kinase activity in vitro. We identified threonine-236 as a critical phosphorylation site on Aurora B that could be a target of Cdc7 or could be an autophosphorylation site stimulated by Cdc7-mediated phosphorylation elsewhere. We found that threonines at both 232 (that has been identified as an autophosphorylation site) and 236 are essential for the kinase activity of Aurora B. Cdc7 down regulation or inhibition reduced Aurora B activity in vivo and led to retarded M-phase progression. SAC imposed by paclitaxel was dramatically reversed by Cdc7 inhibition, similar to the effect of Aurora B inhibition under the similar situation. Our data show that Cdc7 contributes to M-phase progression and to spindle assembly checkpoint most likely through Aurora B activation.
Carna Biosciences Inc Kobe Japan
Department of Genome Medicine Tokyo Metropolitan Institute of Medical Science Tokyo 156 8506 Japan
Department of Physiology Mie University Graduate School of Medicine Tsu Mie 514 8507 Japan
Laboratory of Protein Analyses Tokyo Metropolitan Institute of Medical Science Tokyo 156 8506 Japan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028718
- 003
- CZ-PrNML
- 005
- 20210114154838.0
- 007
- ta
- 008
- 210105s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-019-54738-2 $2 doi
- 035 __
- $a (PubMed)31819079
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Ito, Sayuri $u Department of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.
- 245 10
- $a Cdc7 kinase stimulates Aurora B kinase in M-phase / $c S. Ito, H. Goto, K. Kuniyasu, M. Shindo, M. Yamada, K. Tanaka, GT. Toh, M. Sawa, M. Inagaki, J. Bartek, H. Masai,
- 520 9_
- $a The conserved serine-threonine kinase, Cdc7, plays a crucial role in initiation of DNA replication by facilitating the assembly of an initiation complex. Cdc7 is expressed at a high level and exhibits significant kinase activity not only during S-phase but also during G2/M-phases. A conserved mitotic kinase, Aurora B, is activated during M-phase by association with INCENP, forming the chromosome passenger complex with Borealin and Survivin. We show that Cdc7 phosphorylates and stimulates Aurora B kinase activity in vitro. We identified threonine-236 as a critical phosphorylation site on Aurora B that could be a target of Cdc7 or could be an autophosphorylation site stimulated by Cdc7-mediated phosphorylation elsewhere. We found that threonines at both 232 (that has been identified as an autophosphorylation site) and 236 are essential for the kinase activity of Aurora B. Cdc7 down regulation or inhibition reduced Aurora B activity in vivo and led to retarded M-phase progression. SAC imposed by paclitaxel was dramatically reversed by Cdc7 inhibition, similar to the effect of Aurora B inhibition under the similar situation. Our data show that Cdc7 contributes to M-phase progression and to spindle assembly checkpoint most likely through Aurora B activation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a aurora kinasa B $x metabolismus $7 D064107
- 650 _2
- $a buněčný cyklus $7 D002453
- 650 _2
- $a proteiny buněčného cyklu $x metabolismus $7 D018797
- 650 _2
- $a buněčné dělení $7 D002455
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a centromera $x metabolismus $7 D002503
- 650 _2
- $a chromozomální proteiny, nehistonové $x metabolismus $7 D002868
- 650 _2
- $a HCT116 buňky $7 D045325
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hmyz $7 D007313
- 650 _2
- $a mitóza $7 D008938
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a protein-serin-threoninkinasy $x metabolismus $7 D017346
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a aparát dělícího vřeténka $x metabolismus $7 D008941
- 650 _2
- $a survivin $x metabolismus $7 D000077022
- 650 _2
- $a threonin $x chemie $7 D013912
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Goto, Hidemasa $u Department of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan.
- 700 1_
- $a Kuniyasu, Kinue $u Department of Molecular Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, 980-8575, Japan.
- 700 1_
- $a Shindo, Mayumi $u Laboratory of Protein Analyses, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.
- 700 1_
- $a Yamada, Masayuki $u Medical Education Center, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 77900, Olomouc, Czech Republic.
- 700 1_
- $a Tanaka, Kozo $u Department of Molecular Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, 980-8575, Japan.
- 700 1_
- $a Toh, Gaik-Theng $u Department of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.
- 700 1_
- $a Sawa, Masaaki $u Carna Biosciences, Inc., Kobe, Japan.
- 700 1_
- $a Inagaki, Masaki $u Department of Physiology, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan.
- 700 1_
- $a Bartek, Jiri $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 77900, Olomouc, Czech Republic. Danish Cancer Society Research Center, Copenhagen, Denmark. Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
- 700 1_
- $a Masai, Hisao $u Department of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan. masai-hs@igakuken.or.jp.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 18622
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31819079 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154834 $b ABA008
- 999 __
- $a ok $b bmc $g 1609053 $s 1119898
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 9 $c 1 $d 18622 $e 20191209 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20210105